Vicarious Surgical Business Combination Approved; Stock to Begin Trading on the New York Stock Exchange as “RBOT”
Vicarious Surgical to debut on NYSE as a disruptive next-generation surgical robotics company Approximately $220 million in gross cash proceeds to catalyze advancement of Vicarious Surgical’s robotic technology, clinical programs, […]